Semofull Injection | Semaglutide | GLP-1 Receptor Agonist | Diabetes & Weight Management Supplier Semofull Injection contains Semaglutide, a GLP-1 receptor agonist used for the management of type 2 diabetes and weight control. It helps regulate blood sugar levels and supports weight reduction under medical supervision. 🔍 Keywords Semaglutide Injection, GLP-1 Agonist, Type 2 Diabetes Treatment, Weight Loss Injection, Antidiabetic Medicine Supplier, Pharma Exporter India 🔹 Product Category Specialty Medicine | Antidiabetic | GLP-1 Therapy 🔹 Composition Semaglutide (strength as per COA) 🔹 Uses / Indications ✔ Type 2 Diabetes Mellitus ✔ Blood sugar control ✔ Weight management (as prescribed) ✔ Cardiometabolic support 🔹 Key Benefits ✔ Improves glycemic control ✔ Supports weight reduction ✔ Once-weekly dosing (typically) ✔ Widely used in modern diabetes care 🔹 Dosage & Administration ✔ Subcutaneous injection ✔ Administered as prescribed by physician ✔ Usually once weekly 🔹 Packaging & Supply ✔ Pre-filled pen / vial (as available) ✔ Cold-chain export packaging available ✔ Bulk supply supported 🔹 Storage Instructions ✔ Store at 2–8°C ✔ Do not freeze ✔ Protect from light 🔹 Certifications ✔ WHO-GMP Certified ✔ COA & COPP Available 🌍 Global Export Supply USA, UK, UAE, Singapore, India, Philippines, Vietnam, South Africa, Nigeria, Kenya, Brazil, Mexico, Peru 📍 Location: Nagpur, Maharashtra, India 📞 Contact for Bulk Orders +91 8007161282 +91 9970011496 📧 Email: sales@pacificmedicines.com